Qurient Co Ltd
115180
Company Profile
Business description
Qurient Co Ltd is a South Korea based biotech company. It is engaged in network research & development business model, integrating research and drug development programs with a new mechanism. Its pipeline products include Q301 for the treatment of atopic dermatitis; Q203 treats MDR/XDR/TDR TB, and Q701 is a drug-resistant cancer immuno-oncology.
Contact
C-dong 8th Floor, 242, Pangyo-ro
Bundang-gu
Seongnam-siGyeonggi-do13487
KORT: +82 3180601600
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
30
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,809.10 | 104.80 | -1.32% |
| CAC 40 | 7,126.02 | 263.00 | 3.83% |
| DAX 40 | 20,562.73 | 891.85 | 4.53% |
| Dow JONES (US) | 39,577.49 | 1,030.96 | -2.54% |
| FTSE 100 | 7,913.25 | 233.77 | 3.04% |
| HKSE | 20,824.20 | 142.42 | 0.69% |
| NASDAQ | 16,421.05 | 703.92 | -4.11% |
| Nikkei 225 | 33,160.17 | 1,448.83 | -4.19% |
| NZX 50 Index | 12,037.67 | 163.76 | -1.34% |
| S&P 500 | 5,276.03 | 180.87 | -3.31% |
| S&P/ASX 200 | 7,602.80 | 106.80 | -1.39% |
| SSE Composite Index | 3,227.65 | 4.02 | 0.12% |